Meningococcal prophylaxis in neurological diseases treated with complement inhibitors: an expert consensus for Germany, Austria, and Switzerland.

Berthele A, Aktas O, Ayzenberg I, Claus H, Lâm TT, Löscher WN, Pröbstel AK, Prüss H, Rademacher N, Ringelstein M, Rommer P, Schara-Schmidt U, Schoser B, Weber JR, Zschüntzsch J, Meisel A, Lünemann JD.

Open source

DOI
10.1177/17562864261442558
Published
2026-05-08
Container
Ther Adv Neurol Disord
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/17562864261442558,
  title = {Meningococcal prophylaxis in neurological diseases treated with complement inhibitors: an expert consensus for Germany, Austria, and Switzerland.},
  author = {Berthele A and  Aktas O and  Ayzenberg I and  Claus H and  Lâm TT and  Löscher WN and  Pröbstel AK and  Prüss H and  Rademacher N and  Ringelstein M and  Rommer P and  Schara-Schmidt U and  Schoser B and  Weber JR and  Zschüntzsch J and  Meisel A and  Lünemann JD.},
  year = {2026},
  journal = {Ther Adv Neurol Disord},
  doi = {10.1177/17562864261442558},
  url = {https://doi.org/10.1177/17562864261442558}
}

RIS

TY  - JOUR
TI  - Meningococcal prophylaxis in neurological diseases treated with complement inhibitors: an expert consensus for Germany, Austria, and Switzerland.
AU  - Berthele A
AU  -  Aktas O
AU  -  Ayzenberg I
AU  -  Claus H
AU  -  Lâm TT
AU  -  Löscher WN
AU  -  Pröbstel AK
AU  -  Prüss H
AU  -  Rademacher N
AU  -  Ringelstein M
AU  -  Rommer P
AU  -  Schara-Schmidt U
AU  -  Schoser B
AU  -  Weber JR
AU  -  Zschüntzsch J
AU  -  Meisel A
AU  -  Lünemann JD.
PY  - 2026
JO  - Ther Adv Neurol Disord
DO  - 10.1177/17562864261442558
UR  - https://doi.org/10.1177/17562864261442558
ER  - 

APA

A, B., O, A., I, A., H, C., TT, L., WN, L., AK, P., H, P., N, R., M, R., P, R., U, S., B, S., JR, W., J, Z., A, M., & JD., L. (2026). Meningococcal prophylaxis in neurological diseases treated with complement inhibitors: an expert consensus for Germany, Austria, and Switzerland.. Ther Adv Neurol Disord. https://doi.org/10.1177/17562864261442558

Source records